Drug discontinuation: Cefazolin in Dextrose Injection
FDA lists 3 presentations as To Be Discontinued. Companies: Baxter Healthcare.
- Published by source
- 2026-10-30
- First seen by Reality Radar
- 2026-11-02
- Last verified
- 2026-11-03
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Cefazolin in Dextrose Injection
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-10-30
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #3568 | new | 2026-11-02 | ea9f29e154cd…3ed6e8 | ac4529a059b9…46a3f9 |
| #3778 | update | 2026-11-03 | 3d4795544065…425861 | 1e2654f27a04…3074e2 |
Chain head: #3807 03071ef7d321…845940